Organization

Prof Patrice Lalive

1 clinical trial

Clinical trial

Immunogenicity of the Recombinant Zoster Vaccine (Shingrix ®) in Multiple Sclerosis Patients Treated With Anti-CD20 Antibodies Compared to Controls- a Phase IV Monocentric Study

Status: Recruiting, Estimated PCD: 2024-12-31